However, this benefit failed to reach statistical significance when evaluating it by BC subtypes (due to small sample sizes) or for patients with histological grade III tumors.
← all excerpts
Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry).
1
—
—